These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 31560714)
1. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma. Liu Y; Song C; Shen F; Zhang J; Song SW PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714 [TBL] [Abstract][Full Text] [Related]
3. IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes. Shen F; Song C; Liu Y; Zhang J; Wei Song S Brain Res; 2019 Feb; 1704():174-186. PubMed ID: 30347220 [TBL] [Abstract][Full Text] [Related]
4. The N Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G Front Immunol; 2021; 12():653711. PubMed ID: 34354698 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization. Zhang X; Sun X; Guo C; Li J; Liang G Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173 [TBL] [Abstract][Full Text] [Related]
6. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment. Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051 [TBL] [Abstract][Full Text] [Related]
7. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma. Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984 [TBL] [Abstract][Full Text] [Related]
8. Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion. Patil SS; Railkar R; Swain M; Atreya HS; Dighe RR; Kondaiah P J Neurooncol; 2015 Jun; 123(2):225-35. PubMed ID: 25944386 [TBL] [Abstract][Full Text] [Related]
9. Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells. Authier A; Farrand KJ; Broadley KW; Ancelet LR; Hunn MK; Stone S; McConnell MJ; Hermans IF Int J Cancer; 2015 Jun; 136(11):2566-78. PubMed ID: 25363661 [TBL] [Abstract][Full Text] [Related]
10. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma. Verma BK; Kondaiah P J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659 [TBL] [Abstract][Full Text] [Related]
11. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394 [TBL] [Abstract][Full Text] [Related]
13. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064 [TBL] [Abstract][Full Text] [Related]
14. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma. Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T Front Immunol; 2021; 12():637053. PubMed ID: 34108959 [TBL] [Abstract][Full Text] [Related]
15. SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia. Geraldo LH; Xu Y; Jacob L; Pibouin-Fragner L; Rao R; Maissa N; Verreault M; Lemaire N; Knosp C; Lesaffre C; Daubon T; Dejaegher J; Solie L; Rudewicz J; Viel T; Tavitian B; De Vleeschouwer S; Sanson M; Bikfalvi A; Idbaih A; Lu QR; Lima FR; Thomas JL; Eichmann A; Mathivet T J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34181595 [TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma. Lee-Chang C; Rashidi A; Miska J; Zhang P; Pituch KC; Hou D; Xiao T; Fischietti M; Kang SJ; Appin CL; Horbinski C; Platanias LC; Lopez-Rosas A; Han Y; Balyasnikova IV; Lesniak MS Cancer Immunol Res; 2019 Dec; 7(12):1928-1943. PubMed ID: 31530559 [TBL] [Abstract][Full Text] [Related]
18. Local Targeting of NAD Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997 [TBL] [Abstract][Full Text] [Related]
20. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas. Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J Front Immunol; 2020; 11():585034. PubMed ID: 33193404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]